The serum levels of the soluble transferrin receptor (sTfR) are strongly increased in patients with AID, but reduced in those with ACD and chemotherapy-induced anemia, making this parameter unsuitable for the assessment of iron homeostasis [25]. Here, TFRC is linked to anemia (phenotype).